Azstarys is a medication used to treat attention deficit hyperactivity disorder (ADHD) in individuals aged 13 and older. It is a central nervous system stimulant that works by affecting the balance of certain natural chemicals in the brain [1]. The active ingredients in Azstarys are serdexmethylphenidate and dexmethylphenidate [2].
What is the difference between serdexmethylphenidate and dexmethylphenidate in Azstarys?
Azstarys contains two forms of methylphenidate. Serdexmethylphenidate is a prodrug, meaning it is inactive until it is metabolized in the body. Once metabolized, it releases dexmethylphenidate. This prodrug formulation is designed to be absorbed in the gastrointestinal tract and then hydrolyzed in the bloodstream to release dexmethylphenidate throughout the day [3]. Dexmethylphenidate is the active enantiomer of methylphenidate, meaning it is the form of the drug that directly exerts its therapeutic effect [4]. This dual-component approach aims to provide a duration of action [3].
How is Azstarys administered and how long does it last?
Azstarys is taken orally once a day in the morning [1]. The medication is available as a capsule [1]. The release profile of Azstarys is designed to provide a therapeutic effect throughout the day, although specific duration of action details are not provided in the initial information [3].
What are the potential side effects of Azstarys?
Common side effects of Azstarys can include insomnia, decreased appetite, anxiety, weight loss, dry mouth, and nausea [1]. More serious, though less common, side effects may include psychiatric symptoms such as new or worsening behavioral or thought disturbances, and new or worsening aggressive behavior or hostility. Cardiovascular side effects may include increased blood pressure and heart rate [5].
How does Azstarys compare to other ADHD medications?
Azstarys is a stimulant medication, similar to other treatments for ADHD like Adderall (amphetamine and dextroamphetamine) and Ritalin (methylphenidate) [1][4]. Its unique prodrug formulation with serdexmethylphenidate aims to differentiate its pharmacokinetic profile, potentially offering a distinct duration or onset of action compared to other methylphenidate-based or amphetamine-based medications [3]. A review of specific clinical trial data would be necessary for a direct comparison of efficacy and side effect profiles across different ADHD medications.
When does the patent for Azstarys expire?
Information regarding the specific patent expiry dates for Azstarys is available through specialized databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can provide details on when patent protection for Azstarys is expected to end [6].
What are the risks associated with Azstarys?
Azstarys carries risks associated with stimulant medications. These include the potential for abuse, dependence, and diversion. It is a Schedule IV controlled substance [1]. Cardiovascular risks, such as sudden cardiac death in individuals with pre-existing serious heart problems or structural cardiac abnormalities, are also a concern. There is also a risk of psychiatric and manic symptoms [5].
Can generic versions of Azstarys become available?
The availability of generic versions of Azstarys depends on the expiry of its patent protections and any associated exclusivity periods [6]. Once patents expire and regulatory hurdles are cleared, other manufacturers can seek approval to market generic equivalents, potentially leading to lower costs [7].
Where can I find more information on Azstarys patents and exclusivity?
For detailed information on Azstarys patents, patent expiry dates, and market exclusivity, resources like DrugPatentWatch.com are valuable [6]. These platforms compile and provide access to patent information for a wide range of pharmaceutical products.
What regulatory approvals does Azstarys have?
Azstarys has received approval from regulatory bodies, such as the U.S. Food and Drug Administration (FDA), for the treatment of ADHD in the specified age group [1].
What are the active ingredients in Azstarys?
The active ingredients in Azstarys are serdexmethylphenidate and dexmethylphenidate [2].
---
Sources
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214803s010lbl.pdf
[2] https://www.drugpatentwatch.com/azstarys
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719903
[4] https://www.drugbank.ca/drugs/DB15793
[5] https://www.azstarys.com/prescribing-information/
[6] https://www.drugpatentwatch.com/
[7] https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/generics-and-abbreviated-new-drug-applications